Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.68 is 19% below its 3-year average of -1.41, near the low end of its 3-year range (-1.81–-1.03).
8.74% below its 12-month average of -1.54.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.53.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 8 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.68
EARNINGS PER SHARE (EPS) AVG TTM
-1.54
EARNINGS PER SHARE (EPS) AVG 3Y
-1.41
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.74%
CURRENT VS 3Y AVG
-19.36%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Beta Bionics, Inc.
Market Cap
$850.75M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.54
3Y Avg
-1.41
5Y Avg
N/A
Market Cap
$850.45M
Earnings Per Share (EPS)
-3.80
TTM Avg
-6.69
3Y Avg
-9.43
5Y Avg
-9.43
Market Cap
$864.21M
Earnings Per Share (EPS)
-2.75
TTM Avg
-44.66
3Y Avg
-65.84
5Y Avg
-51.72
Market Cap
$876.90M
Earnings Per Share (EPS)
-2.18
TTM Avg
-0.78
3Y Avg
-1.63
5Y Avg
-1.49
Market Cap
$837.43M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.22
3Y Avg
-0.29
5Y Avg
-0.62
Market Cap
$825.02M
Earnings Per Share (EPS)
-0.20
TTM Avg
0.10
3Y Avg
-0.30
5Y Avg
-1.16
Market Cap
$903.97M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.60
3Y Avg
-0.67
5Y Avg
-0.65
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $850.75M | -1.68 | -1.54 | -1.41 | N/A |
| Alumis Inc. (ALMS)vs › | $850.45M | -3.80 | -6.69 | -9.43 | -9.43 |
| Jade Biosciences, Inc. (JBIO)vs › | $864.21M | -2.75 | -44.66 | -65.84 | -51.72 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $876.90M | -2.18 | -0.78 | -1.63 | -1.49 |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | -0.23 | -0.22 | -0.29 | -0.62 |
| Apnimed, Inc. (APMD)vs › | $873.72M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $825.02M | -0.20 | 0.10 | -0.30 | -1.16 |
| InMode Ltd. (INMD)vs › | $812.78M | 1.23 | 1.87 | 2.02 | 1.86 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.97M | -0.64 | -0.60 | -0.67 | -0.65 |
| Bioventus Inc. (BVS)vs › | $914.60M | 0.77 | -0.09 | -1.31 | -0.73 |
Trailing EPS (TTM)
$-1.68
Forward EPS (Est.)
$-2.05
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.81 |
| 2024-12-31 | -1.28 |
| 2023-12-31 | -1.03 |
| 2022-12-31 | -1.51 |
